NCT04333706 2026-03-10
EMPOWER
University of Southern California
Phase 1/2 Recruiting
Clinical Trials
75 trialsNCT04723810 2026-03-09
TumorGlow Intraoperative Molecular Imaging (IMI)
University of Pennsylvania
Phase 1/2 Recruiting
NCT04713046 2026-03-05
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Recruiting
NCT05004116 2026-03-04
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Recruiting
NCT07354100 2026-03-04
(BLOOM)
University of Chicago
Phase 1/2 Not yet recruiting
NCT06211933 2026-02-12
PULS
Centre Leon Berard
Phase 1/2 Suspended
NCT05039632 2026-02-06
Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT02813135 2026-01-16
ESMART
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
NCT05741242 2026-01-15
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Phase 1/2 Enrolling by invitation
NCT05276284 2026-01-14
TEMPLE
Rigshospitalet, Denmark
Phase 1/2 Completed
NCT06320405 2025-12-29
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
OHSU Knight Cancer Institute
Phase 1/2 Recruiting
NCT05566574 2025-12-17
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT04021043 2025-12-03
BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT04266912 2025-11-25
Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors
M.D. Anderson Cancer Center
Phase 1/2 Active not recruiting
NCT06311851 2025-11-25
Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Pardis Noor Medical Imaging and Cancer Center
Phase 1/2 Recruiting
NCT05847686 2025-11-05
Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer
University of Washington
Phase 1/2 Completed
NCT02130492 2025-10-23
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
Weill Medical College of Cornell University
Phase 1/2 Suspended
NCT05116072 2025-09-25
TPIAT-01
University Hospital, Lille
Phase 1/2 Recruiting
NCT05697406 2025-09-22
HC-MRI
University of Maryland, Baltimore
Phase 1/2 Recruiting
NCT05046171 2025-07-22
Decreasing Polypharmacy in Older Adults With Curable Cancers Trial
University of Rochester
Phase 1/2 Active not recruiting
NCT07032142 2025-06-22
ARCTURUS
D'Or Institute for Research and Education
Phase 1/2 Not yet recruiting
NCT05413473 2025-06-15
Northern Alberta Linac-MR Image-Guided Radiotherapy (Northern LIGHTs-2)
AHS Cancer Control Alberta
Phase 1/2 Recruiting
NCT04706715 2025-05-31
LAG3 PET Imaging in Advanced Solid Tumors
University Medical Center Groningen
Phase 1/2 Active not recruiting
NCT05674825 2025-05-15
MCW I-PREDICT
Medical College of Wisconsin
Phase 1/2 Recruiting
NCT06827080 2025-02-14
Study on the Safety, Tolerability, and Preliminary Efficacy of 161Tb-NYM032 in Patients with Metastatic Castration-Resistant Prostate Cancer
Mianyang Central Hospital
Phase 1/2 Not yet recruiting
NCT01542879 2024-11-25
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Stanford University
Phase 1/2 Recruiting
NCT06147505 2024-10-29
XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Dushu Lake Hospital Affiliated to Soochow University
Phase 1/2 Suspended
NCT03296137 2024-10-26
Adoptive Cell Therapy Across Cancer Diagnoses
Herlev Hospital
Phase 1/2 Completed
NCT06612632 2024-09-25
Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Recruiting
NCT01581840 2024-07-01
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Federation Francophone de Cancerologie Digestive
Phase 1/2 Completed
NCT06456138 2024-06-13
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
Shanghai Chest Hospital
Phase 1/2 Not yet recruiting
NCT05101356 2024-05-21
A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma
University of California, Davis
Phase 1/2 Recruiting
NCT03190811 2024-02-07
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors
Capital Medical University
Phase 1/2 Completed
NCT05289076 2023-12-01
CRLM-Z
University Hospital, Linkoeping
Phase 1/2 Unknown
NCT04288518 2023-10-23
Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose.
Tomsk National Research Medical Center of the Russian Academy of Sciences
Phase 1/2 Completed
NCT03722108 2023-10-16
REGIRI
UNICANCER
Phase 1/2 Terminated
NCT04534738 2023-09-22
DANICA
University of Rochester
Phase 1/2 Completed
NCT05506566 2023-09-21
68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies
First Affiliated Hospital of Fujian Medical University
Phase 1/2 Unknown
NCT05515783 2023-09-21
68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies
First Affiliated Hospital of Fujian Medical University
Phase 1/2 Unknown
NCT04538950 2023-09-13
PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy
Mayo Clinic
Phase 1/2 Completed
NCT05947487 2023-07-17
CD70 Targeted CAR-T Cells in CD70 Positive Advanced/Metastatic Solid Tumors
Chinese PLA General Hospital
Phase 1/2 Recruiting
NCT05834231 2023-04-28
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
Mansoura University
Phase 1/2 Unknown
NCT05175235 2023-03-03
Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements
National University Hospital, Singapore
Phase 1/2 Unknown
NCT05438368 2022-06-30
GD2/CD70 Bi-specific CAR-T Cell Therapy
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Recruiting
NCT05437341 2022-06-29
PSMA/CD70 Bi-specific CAR-T Cell Therapy
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Recruiting
NCT03695757 2021-07-06
Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG
Ajou University School of Medicine
Phase 1/2 Completed
NCT04536454 2021-05-11
SenPET
University Hospital Tuebingen
Phase 1/2 Unknown
NCT02564367 2021-04-29
S-1 adjuvant
AIO-Studien-gGmbH
Phase 1/2 Completed
NCT03315546 2020-10-09
TEDDI
Rigshospitalet, Denmark
Phase 1/2 Recruiting
NCT01896856 2020-10-06
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed